These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 27158896)

  • 1. Metabolic Characterization of Advanced Liver Fibrosis in HCV Patients as Studied by Serum 1H-NMR Spectroscopy.
    Embade N; Mariño Z; Diercks T; Cano A; Lens S; Cabrera D; Navasa M; Falcón-Pérez JM; Caballería J; Castro A; Bosch J; Mato JM; Millet O
    PLoS One; 2016; 11(5):e0155094. PubMed ID: 27158896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolomic analysis with
    Gabbani T; Marsico M; Bernini P; Lorefice E; Grappone C; Biagini MR; Milani S; Annese V
    Dig Liver Dis; 2017 Dec; 49(12):1338-1344. PubMed ID: 28625405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteomic fingerprinting in HIV/HCV co-infection reveals serum biomarkers for the diagnosis of fibrosis staging.
    Golizeh M; Melendez-Pena CE; Ward BJ; Saeed S; Santamaria C; Conway B; Cooper C; Klein MB; Ndao M;
    PLoS One; 2018; 13(4):e0195148. PubMed ID: 29608613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum microRNA-122 and Wisteria floribunda agglutinin-positive Mac-2 binding protein are useful tools for liquid biopsy of the patients with hepatitis B virus and advanced liver fibrosis.
    Nakamura M; Kanda T; Jiang X; Haga Y; Takahashi K; Wu S; Yasui S; Nakamoto S; Yokosuka O
    PLoS One; 2017; 12(5):e0177302. PubMed ID: 28475652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimation of copper and iron burden in biological samples of various stages of hepatitis C and liver cirrhosis patients.
    Arain SA; Kazi TG; Afridi HI; Talpur FN; Mughal MA; Shah F; Arain SS; Panhwar AH
    Biol Trace Elem Res; 2014 Aug; 160(2):197-205. PubMed ID: 24973874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum thioredoxin levels as an indicator of oxidative stress in patients with hepatitis C virus infection.
    Sumida Y; Nakashima T; Yoh T; Nakajima Y; Ishikawa H; Mitsuyoshi H; Sakamoto Y; Okanoue T; Kashima K; Nakamura H; Yodoi J
    J Hepatol; 2000 Oct; 33(4):616-22. PubMed ID: 11059866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Do serum markers of liver fibrosis vary by HCV infection in patients with alcohol use disorder?
    Sanvisens A; Muñoz A; Bolao F; Zuluaga P; Farré M; Jarrin I; Tor J; Muga R
    Drug Alcohol Depend; 2018 Jul; 188():180-186. PubMed ID: 29778771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toxic effects of chronic low-dose exposure of thioacetamide on rats based on NMR metabolic profiling.
    Wei DD; Wang JS; Wang PR; Li MH; Yang MH; Kong LY
    J Pharm Biomed Anal; 2014 Sep; 98():334-8. PubMed ID: 24996005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibro-α score as a simple and useful non-invasive test for predicting significant liver fibrosis in chronic hepatitis C patients.
    Omran MM; Farid K; Emran TM; Attallah AA
    Arab J Gastroenterol; 2011 Jun; 12(2):74-9. PubMed ID: 21684477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New multi protein patterns differentiate liver fibrosis stages and hepatocellular carcinoma in chronic hepatitis C serum samples.
    Göbel T; Vorderwülbecke S; Hauck K; Fey H; Häussinger D; Erhardt A
    World J Gastroenterol; 2006 Dec; 12(47):7604-12. PubMed ID: 17171788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aspartate transaminase to platelet ratio index in hepatitis C virus and Schistosomiasis coinfection.
    Derbala M; Elbadri ME; Amer AM; AlKaabi S; Sultan KH; Kamel YM; Elsayed EH; Avades TY; Chandra P; Shebl FM
    World J Gastroenterol; 2015 Dec; 21(46):13132-9. PubMed ID: 26674154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advancing donor liver age and rapid fibrosis progression following transplantation for hepatitis C.
    Wali M; Harrison RF; Gow PJ; Mutimer D
    Gut; 2002 Aug; 51(2):248-52. PubMed ID: 12117889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leukopenia and thrombocytopenia in hemodialysis patients with hepatitis B or C virus infection and non-hemodialysis patients with hepatitis cirrhosis.
    Ng YY; Lin CC; Wu SC; Hwang SJ; Ho CH; Yang WC; Lee SD
    Clin Nephrol; 2002 Apr; 57(4):289-95. PubMed ID: 12005245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolomic approach by 1H NMR spectroscopy of serum for the assessment of chronic liver failure in patients with cirrhosis.
    Amathieu R; Nahon P; Triba M; Bouchemal N; Trinchet JC; Beaugrand M; Dhonneur G; Le Moyec L
    J Proteome Res; 2011 Jul; 10(7):3239-45. PubMed ID: 21568267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of hepatitis B and C virus infections on the natural history of compensated cirrhosis: a cohort study of 297 patients.
    Fattovich G; Pantalena M; Zagni I; Realdi G; Schalm SW; Christensen E;
    Am J Gastroenterol; 2002 Nov; 97(11):2886-95. PubMed ID: 12425564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepcidin levels and iron status in beta-thalassemia major patients with hepatitis C virus infection.
    Hendy OM; Allam M; Allam A; Attia MH; El Taher S; Eldin MM; Ali A
    Egypt J Immunol; 2010; 17(2):33-44. PubMed ID: 23082485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic Characterization of Peripheral Host Responses to Drainage-Resistant Klebsiella pneumoniae Liver Abscesses by Serum 1H-NMR Spectroscopy.
    Chang Z; Wang H; Li B; Liu Z; Zheng J
    Front Cell Infect Microbiol; 2018; 8():174. PubMed ID: 29911073
    [No Abstract]   [Full Text] [Related]  

  • 18. A Cross-Platform Metabolomics Comparison Identifies Serum Metabolite Signatures of Liver Fibrosis Progression in Chronic Hepatitis C Patients.
    Shanmuganathan M; Sarfaraz MO; Kroezen Z; Philbrick H; Poon R; Don-Wauchope A; Puglia M; Wishart D; Britz-McKibbin P
    Front Mol Biosci; 2021; 8():676349. PubMed ID: 34414211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased intrahepatic and circulating levels of endoglin, a TGF-beta1 co-receptor, in patients with chronic hepatitis C virus infection: relationship to histological and serum markers of hepatic fibrosis.
    Clemente M; Núñez O; Lorente R; Rincón D; Matilla A; Salcedo M; Catalina MV; Ripoll C; Iacono OL; Bañares R; Clemente G; García-Monzón C
    J Viral Hepat; 2006 Sep; 13(9):625-32. PubMed ID: 16907850
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.